SCHEMBL6770744

SCHEMBL6770744

CC(C)c1ccc(-n2nc(Cc3ccccc3)c3c2CC(C)(C)C(C#N)C3=O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 1/20 0.38
NPBWR1 P48145 1/20 0.35
MCHR1 Q99705 1/20 0.35
LMNA P02545 4/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
CYP3A4 P08684 2/20 0.34
HTT P42858 2/20 0.34
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MCL1 Q07820 2/20 0.32
BCL2 P10415 1/20 0.32
MDM2 Q00987 1/20 0.32
KDM5A P29375 1/20 0.32
HPGD P15428 3/20 0.32
OPRM1 P35372 1/20 0.32
ALPL P05186 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6770787 0.86 MDM2 (0.38) CYP2C9CYP2C19CYP1A2CYP2D6NPBWR1
SCHEMBL6770449 0.86 CCNA2 (0.41) CYP2C9CYP2C19CYP1A2CYP2D6NPBWR1
SCHEMBL6770689 0.86 IDH1 (0.30) CYP2C9CYP2C19CYP1A2LMNAMEN1
SCHEMBL6770531 0.85 MEN1 (0.40) CYP2C9CYP2C19CYP1A2CYP2D6LMNA
SCHEMBL6767123 0.82 MAPT (0.32) OPRM1MAPT
SCHEMBL6777603 0.80 MEN1 (0.32) CYP2C9CYP2C19CYP1A2CYP2D6LMNA
SCHEMBL6777607 0.80 MEN1 (0.32) CYP2C9CYP2C19CYP1A2CYP2D6LMNA
SCHEMBL6766535 0.79 DHODH (0.36) CYP2C9CYP2C19CYP1A2CYP2D6LMNA
SCHEMBL6771211 0.78 MEN1 (0.34) CYP2C9CYP2C19CYP1A2LMNAMEN1
SCHEMBL6770141 0.78 PTGS1 (0.41) CYP2C9CYP2C19CYP1A2NPBWR1MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed